Skip to main navigation Skip to search Skip to main content

Pre-clinical Evaluation of 177Lu-Labeled Trastuzumab Targeting HER2 for Radioimmunotherapeutic and Radioimmunodiagnostic Applications

  • G.L. Ray
  • , K. Baidoo
  • , L. Keller
  • , D. Milenic
  • , M. Brechbiel
  • , Geoffrey Ray
  • NIH/NCI, Bethesda, MD

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalInternational Journal of Radiation Oncology Biology Physics
Volume81
Issue number2
DOIs
StatePublished - Oct 1 2011

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this